Cleared Traditional

K200313 - VIVO (FDA 510(k) Clearance)

Sep 2020
Decision
221d
Days
Class 2
Risk

K200313 is an FDA 510(k) clearance for the VIVO. This device is classified as a Computer, Diagnostic, Programmable (Class II - Special Controls, product code DQK).

Submitted by Catheter Precision, Inc. (Mt. Olive, US). The FDA issued a Cleared decision on September 14, 2020, 221 days after receiving the submission on February 6, 2020.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1425.

Submission Details

510(k) Number K200313 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 06, 2020
Decision Date September 14, 2020
Days to Decision 221 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code DQK - Computer, Diagnostic, Programmable
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.1425

Similar Devices - DQK Computer, Diagnostic, Programmable

All 60
HemoSphere Nano Monitor (HSNANO1)
K253186 · Edwards Lifesciences, LLC · Feb 2026
CARTO™ 3 EP Navigation System V8.4
K252972 · Biosense Webster, Inc. · Feb 2026
IOPS Visionary System (MC-3)
K254089 · Centerline Biomedical, Inc. · Feb 2026
Holter ECG and ABP system (HolterABP)
K251591 · Edan Instruments, Inc. · Feb 2026
SafeBeat Rx App
K251218 · Safebeat Rx, Inc. · Feb 2026
NorthStar™ Mapping System
K252164 · Imricor Medical Systems · Jan 2026